Guafecainol

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) L68QKU1H9U. European Medicines Agency schedules Guafecainol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07969MIG. Guafecainol generally arises in the molecular formula C16H27NO4. The term GUAFECAINOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, no 10 1978, list 18.) GUAFECAINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule guafecainol under HS 29221980 and SITC 51461. As of Q4 2014, GUAFECAINOL remains US FDA's Preferred Term for this commodity. Guafecainol bears US NLM identifiers UMLS ID C2827163 and NCI Concept Code C83738. SMILES: O(CCN(CC)CC)CC(O)COC1C(OC)CCCC1.